Stocks and Investing Stocks and Investing
Tue, November 9, 2021

Marc Goodman Maintained (AXSM) at Buy with Decreased Target to $65 on, Nov 9th, 2021


Published on 2024-10-27 18:34:55 - WOPRAI, Marc Goodman
  Print publication without navigation


Marc Goodman of SVB Leerink, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Decreased Target from $75 to $65 on, Nov 9th, 2021.

Marc has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Marc's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 10th, 2021


These are the ratings of the 3 analyists that currently disagree with Marc


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $180 on, Monday, August 30th, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, August 10th, 2021
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $160 on, Tuesday, August 10th, 2021
Contributing Sources